Dr. Rapisuwon on Clinical Trial Barriers in the United States in Mucosal Melanoma
Suthee Rapisuwon, MD, discusses clinical trial barriers for patients with mucosal melanoma in the United States.
Dr. Rapisuwon on the Potential Utility of Toripalimab in Melanoma Subtypes
Suthee Rapisuwon, MD, discusses the potential utility of toripalimab in melanoma subtypes.
Dr. Rapisuwon on Frontline Immunotherapy Vs Targeted Therapy in Melanoma Subtypes
Suthee Rapisuwon, MD, discusses the utility of frontline immunotherapy vs targeted therapy in acral and mucosal melanoma.
Dr. Rapisuwon on Biologic Differences Between Mucosal and Cutaneous Melanoma
Suthee Rapisuwon, MD, discusses the biologic differences between mucosal and cutaneous melanoma.
Dr. Rapisuwon on the Frontline Treatment of Acral and Mucosal Melanoma
Suthee Rapisuwon, MD, discusses the frontline treatment of acral and mucosal melanoma.
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512